Form 4: Guardant Health Director Myrtle S. Potter Reports Stock Transactions
SEC Form 4 Filing
Director Myrtle S. Potter reports the disposition of 68 common stock units of Guardant Health, Inc. on March 15, 2024, through the vesting of restricted stock units.
Summary
- On March 15, 2024, Myrtle S. Potter, a director of Guardant Health, Inc., reported a transaction involving the disposition of 68 shares of common stock.
- The transaction occurred due to the vesting of restricted stock units.
- Following the transaction, Potter directly owns 7,514 shares of Guardant Health common stock and 1,300 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing regarding stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| 10/15/2022 | 25% of the restricted stock units vested |
| 03/15/2024 | Date of transaction: Disposition of 68 common stock units due to vesting of restricted stock units |
| 03/18/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.